Cargando…

Structural Basis of VSIG3: The Ligand for VISTA

B7 family members and their receptors play key roles in regulating T cell responses, and constitute very attractive targets for developing immunotherapeutic drugs. V-Set and Immunoglobulin domain containing 3 (VSIG3), a ligand for the novel B7 family immune checkpoint V-domain immunoglobulin suppres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Xiaoxue, Chen, Caiping, Chen, Wenting, Jiang, Jingwei, Wang, Lanlan, Li, Tingting, Sun, Hongbin, Liu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027081/ https://www.ncbi.nlm.nih.gov/pubmed/33841409 http://dx.doi.org/10.3389/fimmu.2021.625808

Ejemplares similares

The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer
por: Xie, Xiaoxue, et al.
Publicado: (2020)

M351‐0056 is a novel low MW compound modulating the actions of the immune‐checkpoint protein VISTA
por: Hu, Xinlei, et al.
Publicado: (2021)

VSIG4 interaction with heparan sulfates inhibits VSIG4–complement binding
por: Ebstein, Sarah Y, et al.
Publicado: (2023)

V-Set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy
por: Zhou, Xia, et al.
Publicado: (2022)

Ligand-Receptor Interactions of Galectin-9 and VISTA Suppress Human T Lymphocyte Cytotoxic Activity
por: Yasinska, Inna M., et al.
Publicado: (2020)

VSIG4 mediates transcriptional inhibition of Nlrp3 and Il-1β in macrophages
por: Huang, Xiaoyong, et al.
Publicado: (2019)

Structural Basis for Recognition of Cellular and Viral Ligands by NK Cell Receptors
por: Li, Yili, et al.
Publicado: (2014)

Upregulation of VSIG4 in Type 2 Diabetic Kidney Disease
por: Han, Sang Youb, et al.
Publicado: (2022)

VISTA Blockade Aggravates Bone Loss in Experimental Murine Apical Periodontitis
por: Yang, Fuhua, et al.
Publicado: (2021)

Defining the Signature of VISTA on Myeloid Cell Chemokine Responsiveness
por: Broughton, Thomas W. K., et al.
Publicado: (2019)

VISTA: A Target to Manage the Innate Cytokine Storm
por: ElTanbouly, Mohamed A., et al.
Publicado: (2021)

VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism
por: Li, Jialin, et al.
Publicado: (2017)

VISTA expression and patient selection for immune-based anticancer therapy
por: Martin, Alexander S., et al.
Publicado: (2023)

The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma
por: Issam Salah, Nour el Imane, et al.
Publicado: (2023)

Immune-checkpoint protein VISTA in allergic, autoimmune disease and transplant rejection
por: Zheng, Meijun, et al.
Publicado: (2023)

VSIG4 Silencing Inhibits Glioblastoma Growth by Regulating the JAK2/STAT3 Pathway
por: Zheng, Congying, et al.
Publicado: (2023)

Molecular Basis and Role of Siglec-7 Ligand Expression on Chronic Lymphocytic Leukemia B Cells
por: Chang, Lan-Yi, et al.
Publicado: (2022)

Adhesion Protein VSIG1 Is Required for the Proper Differentiation of Glandular Gastric Epithelia
por: Oidovsambuu, Odgerel, et al.
Publicado: (2011)

Low expression of VSIG4 is associated with poor prognosis in hepatocellular carcinoma patients with hepatitis B infection
por: Zhu, Sicong, et al.
Publicado: (2018)

Immune checkpoint protein VSIG4 as a biomarker of aging in murine adipose tissue
por: Hall, Brandon M., et al.
Publicado: (2020)

VISTA Re-programs Macrophage Biology Through the Combined Regulation of Tolerance and Anti-inflammatory Pathways
por: ElTanbouly, Mohamed A., et al.
Publicado: (2020)

Distinct immune stimulatory effects of anti-human VISTA antibodies are determined by Fc-receptor interaction
por: Mostböck, Sven, et al.
Publicado: (2022)

The Structural Basis of Antibody-Antigen Recognition
por: Sela-Culang, Inbal, et al.
Publicado: (2013)

New vistas unfold: Chicken MHC molecules reveal unexpected ways to present peptides to the immune system
por: Halabi, Samer, et al.
Publicado: (2022)

Extracellular Histone H3 Induces Pyroptosis During Sepsis and May Act Through NOD2 and VSIG4/NLRP3 Pathways
por: Shi, Chun-xia, et al.
Publicado: (2020)

Cellular Basis for the Enhanced Efficacy of the Fms-Like Tyrosine Kinase 3 Ligand (FL) Adjuvanted VCG-Based Chlamydia abortus Vaccine
por: Richardson, Shakyra, et al.
Publicado: (2021)

Structural basis for ligand binding modes of CTP synthase
por: Zhou, Xian, et al.
Publicado: (2021)

VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy
por: Shekari, Najibeh, et al.
Publicado: (2023)

The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead
por: Hosseinkhani, Negar, et al.
Publicado: (2021)

VSIG2 promotes malignant progression of pancreatic ductal adenocarcinoma by enhancing LAMTOR2-mediated mTOR activation
por: Xu, Jichuan, et al.
Publicado: (2023)

Negative Immune Checkpoint Protein, VISTA, Regulates the CD4(+) T(reg) Population During Sepsis Progression to Promote Acute Sepsis Recovery and Survival
por: Gray, Chyna C., et al.
Publicado: (2022)

Localization of the Novel Hair Shaft Protein VSIG8 in the Hair Follicle, Nail Unit and Oral Cavity
por: Rice, Robert H., et al.
Publicado: (2011)

VSIG4 Induces Epithelial-Mesenchymal Transition of Renal Tubular Cells under High-Glucose Conditions
por: Gong, Eun-Yeung, et al.
Publicado: (2020)

Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality
por: Reißing, Johanna, et al.
Publicado: (2021)

Structural Basis of IL-1 Family Cytokine Signaling
por: Fields, James K., et al.
Publicado: (2019)

Structural basis of IRGB10 oligomerization by GTP hydrolysis
por: Ha, Hyun Ji, et al.
Publicado: (2023)

Structural Basis for Antigen Recognition by Transglutaminase 2-specific Autoantibodies in Celiac Disease
por: Chen, Xi, et al.
Publicado: (2015)

Structural basis of ligand binding modes of human EAAT2
por: Zhang, Zhenglai, et al.
Publicado: (2022)

Structural basis of ligand recognition in 5-HT(3) receptors
por: Kesters, Divya, et al.
Publicado: (2013)

Structural basis of ligand interaction with atypical chemokine receptor 3
por: Gustavsson, Martin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5ck4q3kr9k2r379aikf49pu93v